HomeICCC • NASDAQ
add
ImmuCell Corp
Previous close
$6.79
Day range
$6.32 - $7.14
Year range
$3.35 - $7.60
Market cap
61.00M USD
Avg Volume
41.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 8.07M | 11.16% |
Operating expense | 2.24M | -13.83% |
Net income | 1.45M | 430.46% |
Net profit margin | 17.94 | 397.51% |
Earnings per share | — | — |
EBITDA | 1.79M | 388.45% |
Effective tax rate | 0.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.60M | 378.93% |
Total assets | 45.62M | 5.97% |
Total liabilities | 16.63M | -9.70% |
Total equity | 28.99M | — |
Shares outstanding | 9.04M | — |
Price to book | 2.10 | — |
Return on assets | 6.16% | — |
Return on capital | 6.48% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.45M | 430.46% |
Cash from operations | 1.57M | 276.06% |
Cash from investing | -329.05K | -367.69% |
Cash from financing | -403.65K | -10.12% |
Net change in cash | 841.14K | 4,672.90% |
Free cash flow | 478.79K | -9.97% |
About
Founded
1982
Headquarters
Website
Employees
71
